VSPharmTech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 14

VSPharmTech General Information

Description

Developer of radiation sensitizer drugs designed to increase the efficacy of anticancer drugs. The company specializes in technology commercialization developed by domestic and overseas anticancer research groups and in mechanism-driven, synergy-equipped radiosensitizers that excel in low toxicity, enabling patients and the healthcare sector to undergo chemotherapy with safe and effective drugs and to offer safe treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 410, 191, Seongseo4chacheomdan-ro
  • Dalseo-gu, Woram-dong
  • Daegu, Shincheon 41256
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room 410, 191, Seongseo4chacheomdan-ro
  • Dalseo-gu, Woram-dong
  • Daegu, Shincheon 41256
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VSPharmTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series B) 17-Sep-2025 Completed Clinical Trials - Phase 2
11. Accelerator/Incubator 21-May-2024 Completed Clinical Trials - Phase 2
10. Accelerator/Incubator 23-Oct-2023 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series B) 19-Jun-2023 Completed Clinical Trials - Phase 2
8. Early Stage VC (Series A) 01-Mar-2022 Completed Clinical Trials - General
7. Early Stage VC 01-Dec-2021 Completed Clinical Trials - General
6. Seed Round 01-May-2020 Completed Startup
5. Accelerator/Incubator 31-Aug-2019 Completed Startup
4. Seed Round 01-Mar-2019 $311K $311K Completed Startup
3. Accelerator/Incubator Completed Startup
To view VSPharmTech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VSPharmTech Patents

VSPharmTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026220309-A1 Head and neck cancer treatment Pending 14-Apr-2025
WO-2026176390-A1 Methods and compositions for enhancing radiation therapy with dopamine receptor (drd2)‑binding compounds Pending 20-Feb-2025
US-20250268892-A1 Treatment of cancer using aripiprazole and anticancer agent Pending 27-Feb-2024
US-20260263453-A1 Treatment of cancer using aripiprazole and anticancer agent Pending 27-Feb-2024
WO-2025181652-A1 Treatment of cancer using aripiprazole and anticancer agent Pending 27-Feb-2024 A61K31/555
To view VSPharmTech’s complete patent history, request access »

VSPharmTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VSPharmTech Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
JCH Investment Venture Capital Minority
Seoul Biohub Accelerator/Incubator
BiiG WAVE Accelerator/Incubator
Korea Venture Investment Fund of Funds Minority
Samho Green Investment Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

VSPharmTech FAQs

  • When was VSPharmTech founded?

    VSPharmTech was founded in 2018.

  • Where is VSPharmTech headquartered?

    VSPharmTech is headquartered in Daegu, South Korea.

  • What is the size of VSPharmTech?

    VSPharmTech has 17 total employees.

  • What industry is VSPharmTech in?

    VSPharmTech’s primary industry is Drug Discovery.

  • Is VSPharmTech a private or public company?

    VSPharmTech is a Private company.

  • What is VSPharmTech’s current revenue?

    The current revenue for VSPharmTech is .

  • How much funding has VSPharmTech raised over time?

    VSPharmTech has raised $6.81M.

  • Who are VSPharmTech’s investors?

    JCH Investment, Seoul Biohub, BiiG WAVE, Korea Venture Investment, and Samho Green Investment are 5 of 14 investors who have invested in VSPharmTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process